Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases

scientific article

Recurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S13277-012-0486-0
P932PMC publication ID3501176
P698PubMed publication ID22976541
P5875ResearchGate publication ID230849922

P50authorMaria Debiec-RychterQ66809340
Vanessa VanspauwenQ66809394
Raf SciotQ66809432
Joanna PrzybylQ117228165
Ignace SamsonQ117265825
Piotr RutkowskiQ125623002
Janusz A SiedleckiQ59559026
P2860cites workTranslocations involving the X chromosome in solid tumors: presentation of two sarcomas with t(X;18)(q13;p11)Q68733627
Translocation X;18 in synovial sarcomaQ70145818
Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcomaQ73821343
A novel type of SYT/SSX fusion: methodological and biological implicationsQ74302601
Re: A novel fusion gene, SYT-SSX4, in synovial sarcomaQ74459625
Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcriptQ78173995
Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in JapanQ80509742
A novel variant of SYT-SSX1 fusion gene in a case of spindle cell synovial sarcomaQ80847758
Molecular characterization of a novel variant of a SYT-SSX1 fusion transcript in synovial sarcomaQ81322396
Correlates of SYT-SSX fusion type in synovial sarcoma: getting more complex but also more interesting?Q81771941
Fusion of SYT to two genes, SSX1 and SSX2, encoding proteins with homology to the Kruppel-associated box in human synovial sarcomaQ24307456
The central proline rich region of POB1/REPS2 plays a regulatory role in epidermal growth factor receptor endocytosis by binding to 14-3-3 and SH3 domain-containing proteinsQ24316124
Small G protein Ral and its downstream molecules regulate endocytosis of EGF and insulin receptorsQ24534185
Molecular diagnosis of synovial sarcoma and characterization of a variant SYT-SSX2 fusion transcriptQ24684124
A novel fusion gene, SYT-SSX4, in synovial sarcoma.Q27777797
Impact of SYT-SSX fusion type on the clinical behavior of synovial sarcoma: a multi-institutional retrospective study of 243 patients.Q27824779
SYT-SSX gene fusion as a determinant of morphology and prognosis in synovial sarcomaQ27851510
Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expressionQ28190079
A novel fusion gene, SS18L1/SSX1, in synovial sarcomaQ28191167
REPS2/POB1 is downregulated during human prostate cancer progression and inhibits growth factor signalling in prostate cancer cellsQ30938786
Clinical impact of molecular and cytogenetic findings in synovial sarcomaQ34082692
Identification of REPS2 as a putative modulator of NF-kappaB activity in prostate cancer cellsQ34325532
EGF signalling in prostate cancer cell lines is inhibited by a high expression level of the endocytosis protein REPS2.Q34354134
Histologic grade, but not SYT-SSX fusion type, is an important prognostic factor in patients with synovial sarcoma: a multicenter, retrospective analysisQ34550816
Updates on the cytogenetics and molecular genetics of bone and soft tissue tumors: chondrosarcoma and other cartilaginous neoplasmsQ35125621
SYT-SSX fusion genes and prognosis in synovial sarcoma.Q36623165
Reps2: a cellular signaling and molecular trafficking nexusQ37930200
A variant of the SYT-SSX2 fusion gene in a case of synovial sarcomaQ40282488
A new human synovial sarcoma cell line, HS-SY-3, with a truncated form of hybrid SYT/SSX1 geneQ40806404
t(X;18) reverse transcriptase-polymerase chain reaction demonstrating a variant transcriptQ42720854
TMEM25, REPS2 and Meis 1: favourable prognostic and predictive biomarkers for breast cancerQ43272255
Novel SYT-SSX fusion transcript variants in synovial sarcomaQ44749236
The SYT-SSX1 variant of synovial sarcoma is associated with a high rate of tumor cell proliferation and poor clinical outcome.Q44785118
A novel FISH assay for SS18-SSX fusion type in synovial sarcomaQ47314970
Prognostic implication of SYT-SSX fusion type and clinicopathological parameters for tumor-related death, recurrence, and metastasis in synovial sarcomaQ47963548
Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma.Q53682869
P433issue6
P921main subjectsynovial sarcomaQ2619315
P304page(s)2245-2253
P577publication date2012-09-14
P1433published inTumor BiologyQ15757842
P1476titleRecurrent and novel SS18-SSX fusion transcripts in synovial sarcoma: description of three new cases
P478volume33

Reverse relations

cites work (P2860)
Q47927686BCOR upregulation in a poorly differentiated synovial sarcoma with SS18L1-SSX1 fusion-A pathologic and molecular pitfall
Q92980126Clinical application of RNA sequencing in sarcoma diagnosis: An institutional experience
Q41617073Detailed analysis of a superficial CD34-positive fibroblastic tumor: A case report and review of the literature
Q93164602Diagnostic Value of TLE1 in Synovial Sarcoma: A Systematic Review and Meta-Analysis
Q55408540Intraneural synovial sarcoma of the tibial nerve.
Q38153685Primary monophasic synovial sarcoma of the kidney: a case report and review of literature
Q39233440Synovial Sarcoma: Advances in Diagnosis and Treatment Identification of New Biologic Targets to Improve Multimodal Therapy.
Q38567366Synovial sarcoma is a gateway to the role of chromatin remodeling in cancer

Search more.